14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
WOK vs BIYA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Baiya International Group Inc. (BIYA) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (52.3/100 HOLD vs. 25.6/100 SELL) after splitting the core matrix 4–3 (led by Valuation Multiples, Growth & Scale), while WOK wins 3–2 across the 6-pillar growth and valuation breakdown. WOK trades at $1.23 (N/M Forward P/E, -41.7% operating margin) versus BIYA at $1.21 (N/M Forward P/E, -45.7% operating margin).
Growth vs. Quality Trade-Off: BIYA earns the overall head-to-head edge with a stronger Unified Composite Score (52.3/100 HOLD vs. WOK 25.6/100 SELL) and -6.11β · 39% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile BIYA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on WOK vs BIYA. Trailing 12-month operating profitability (WOK -41.7% vs BIYA -45.7%) and valuation multiples (WOK N/M vs BIYA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Software - Application value chain with $8.3M market capitalization and -45.7% operating margin.
OpEx & R&D Reinvestment57.2% of Rev ($9.9M)
90D Engineering Disclosures0 Published
Investor FAQ WOK vs BIYA Key Questions & Quantitative Answers
As of Nov 16, 2026, Baiya International Group Inc. (BIYA) captures the overall head-to-head institutional edge over WORK Medical Technology Group LTD Class A (WOK) on higher Unified Composite conviction (52.3/100 HOLD vs. 25.6/100 SELL) after splitting the core matrix 4–3 (led by Valuation Multiples, Growth & Scale), while WOK wins 3–2 across the 6-pillar growth and valuation breakdown. WOK trades at $1.23 (N/M Forward P/E, -41.7% operating margin) versus BIYA at $1.21 (N/M Forward P/E, -45.7% operating margin). Growth vs. Quality Trade-Off: BIYA earns the overall head-to-head edge with a stronger Unified Composite Score (52.3/100 HOLD vs. WOK 25.6/100 SELL) and -6.11β · 39% Vol risk profile, whereas WOK leads top-line expansion (+19.1% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: WOK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 49.1); meanwhile BIYA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.7). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BIYA leads the Growth & Scale pillar: WOK posts +19.1% YoY revenue growth and -95.0% YoY earnings growth on $11M TTM revenue (17.0% gross margin, -41.7% operating margin), compared with BIYA at +53.2% YoY revenue growth and +0.0% YoY earnings growth on $17M TTM revenue (11.5% gross margin, -45.7% operating margin). On trailing 12-month operating scale, WOK generates $11M in USD-normalized revenue versus $17M for BIYA. In operating R&D and SG&A reinvestment, WOK deploys 58.7% of Rev ($6.3M) (0 90-day corporate R&D disclosures) versus 57.2% of Rev ($9.9M) (0 disclosures) for BIYA.
BIYA screens cheaper on headline valuation multiples. WOK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-31.4% EBITDA margin), whereas BIYA trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-45.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against WOK (-19.2% ROE) versus BIYA (-30.8% ROE) capital efficiency.
In options market volatility and institutional positioning, WOK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (38.49β · 153% Vol realized risk). By comparison, BIYA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.11β · 39% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.